Clinical Trials in Baltimore

Showing 5681-5700 of 17,842 trials

Skeletal Metastasis Registry

NCT05058014

This is a prospective, observational study designed to contribute data from patients with symptomatic metastatic bone disease treated at Sibley Memorial Hospital and Johns Hopkins Medicine to an international registry hosted by the Swedish Regional Cancer Centrum in Stockholm, Sweden. This protocol supports a worldwide effort to collect and store information from patients treated for symptomatic bone metastases within the International Skeletal Metastasis Registry (ISMR)

Metastatic Bone Tumor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins50 participantsStarted Aug 2018

Baltimore, Maryland, United States

COMPLETEDPhase 1< 1 mile

Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer

NCT03246074

This research is being done to test the safety of the combination of the study drugs fostamatinib and paclitaxel. This study tests different doses of the drugs to see which doses are safest in people with ovarian cancer when given together.

Ovarian Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins35 participantsStarted Apr 2018

Washington D.C., District of Columbia, United States • Baltimore, Maryland, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 37.6 miles

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

NCT05420961

This a study of V116 in adults ≥50 years of age who previously received a pneumococcal vaccination ≥1 year before enrollment. The primary objectives of this study are to evaluate the safety, tolerability, and immunogenicity of V116.

Pneumonia, Pneumococcal

Merck Sharp & Dohme LLC717 participantsStarted Jul 2022

Birmingham, Alabama, United States • Glendale, Arizona, United States • Tempe, Arizona, United States +48 more locations

Skeletal Metastasis Registry

Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

Find Trials by Condition in Baltimore

A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

WECARE: A Behavioral Intervention for Dementia Caregivers

Promoting Recovery Optimization With WALKing Exercise After Stroke

An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)

Trial Comparing Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings

A Study of LY3022855 In Participants With Breast or Prostate Cancer

ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma

First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms